Search by Drug Name or NDC
NDC 62135-0315-30 Rifampin 150 mg/1 Details
Rifampin 150 mg/1
Rifampin is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Chartwell RX, LLC. The primary component is RIFAMPIN.
MedlinePlus Drug Summary
Rifampin is used with other medications to treat tuberculosis (TB; a serious infection that affects the lungs and sometimes other parts of the body). Rifampin is also used to treat some people who have Neisseria meningitidis (a type of bacteria that can cause a serious infection called meningitis) infections in their noses or throats. These people have not developed symptoms of the disease, and this treatment is used to prevent them from infecting other people. Rifampin should not be used to treat people who have developed symptoms of meningitis. Rifampin is in a class of medications called antimycobacterials. It works by killing the bacteria that cause infection. Antibiotics such as rifampin will not work for colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 62135-0315-30Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Rifampin
Product Information
| NDC | 62135-0315 |
|---|---|
| Product ID | 62135-315_f9244302-8654-6016-e053-6294a90ad64c |
| Associated GPIs | |
| GCN Sequence Number | 009322 |
| GCN Sequence Number Description | rifampin CAPSULE 150 MG ORAL |
| HIC3 | W1G |
| HIC3 Description | ANTITUBERCULAR ANTIBIOTICS |
| GCN | 41260 |
| HICL Sequence Number | 004040 |
| HICL Sequence Number Description | RIFAMPIN |
| Brand/Generic | Generic |
| Proprietary Name | Rifampin |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Rifampin |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 150 |
| Active Ingredient Units | mg/1 |
| Substance Name | RIFAMPIN |
| Labeler Name | Chartwell RX, LLC |
| Pharmaceutical Class | Rifamycin Antibacterial [EPC], Rifamycins [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA065390 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 62135-0315-30 (62135031530)
| NDC Package Code | 62135-315-30 |
|---|---|
| Billing NDC | 62135031530 |
| Package | 30 CAPSULE in 1 BOTTLE (62135-315-30) |
| Marketing Start Date | 2023-04-05 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |